Journal of Clinical Oncology
Results from a phase I study of intraventricular administration of rituximab in patients with recurrent lymphomatous meningitis.
Journal of Clinical Oncology
Treatment of primary CNS lymphoma with induction high-dose methotrexate, temozolomide, rituximab followed by consolidation cytarabine/etoposide: A pilot study with biomarker analysis.
Journal of Clinical Oncology
In Reply.
Journal of Clinical Oncology
Reply to H. Zetterberg et al.
Journal of Clinical Oncology
Interim results of a phase I trial of intraventricular rituximab plus methotrexate in recurrent CNS lymphoma: Macrophage polarization and acquired resistance to therapy.
Journal of Clinical Oncology
Suppressive signals in colorectal cancer: RasGRP1 a new marker for anti-EGFR therapy?.
Journal of Clinical Oncology
Phase I investigation of lenalidomide plus rituximab and outcomes of lenalidomide maintenance in recurrent CNS lymphoma.
Journal of Clinical Oncology